Effect of intravitreal anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration on renal function

James E Neffendorf; Tracey Mare; Andrew R H Simpson; Cristina Soare; Varo Kirthi; Claire C Sharpe; Timothy L Jackson

doi:10.1093/ndt/gfad035

Effect of intravitreal anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration on renal function

James E Neffendorf, Tracey Mare, Andrew R H Simpson, Cristina Soare, Varo Kirthi, Claire C Sharpe, Timothy L Jackson

Ophthalmology

Department of Orthodontics, Queen Mary's Hospital, Sidcup, King's College Hospital NHS Foundation Trust/King's College, London, UK.

Research output: Contribution to journal › Article › peer-review

Abstract

This study did not find any clinically significant change in serum markers of renal function in the one month after intravitreal ranibizumab or aflibercept. It did, however, find a non-significant rise in creatinine with aflibercept, that was not seen with ranibizumab.

Original language	English
Pages (from-to)	1770-1772
Number of pages	3
Journal	Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Volume	38
Issue number	7
Early online date	10 Feb 2023
DOIs	https://doi.org/10.1093/ndt/gfad035
Publication status	Published - 30 Jun 2023

Access to Document

10.1093/ndt/gfad035

Cite this

Neffendorf, J. E., Mare, T., Simpson, A. R. H., Soare, C., Kirthi, V., Sharpe, C. C., & Jackson, T. L. (2023). Effect of intravitreal anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration on renal function. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 38(7), 1770-1772. https://doi.org/10.1093/ndt/gfad035

Neffendorf, James E ; Mare, Tracey ; Simpson, Andrew R H et al. / Effect of intravitreal anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration on renal function. In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2023 ; Vol. 38, No. 7. pp. 1770-1772.

@article{adecb6ff31a745ee8c552f5fdd9f729e,

title = "Effect of intravitreal anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration on renal function",

abstract = "This study did not find any clinically significant change in serum markers of renal function in the one month after intravitreal ranibizumab or aflibercept. It did, however, find a non-significant rise in creatinine with aflibercept, that was not seen with ranibizumab. ",

author = "Neffendorf, {James E} and Tracey Mare and Simpson, {Andrew R H} and Cristina Soare and Varo Kirthi and Sharpe, {Claire C} and Jackson, {Timothy L}",

year = "2023",

month = jun,

day = "30",

doi = "10.1093/ndt/gfad035",

language = "English",

volume = "38",

pages = "1770--1772",

journal = "Nephrology, Dialysis, Transplantation",

issn = "0931-0509",

publisher = "Oxford University Press",

number = "7",

}

Neffendorf, JE, Mare, T, Simpson, ARH, Soare, C, Kirthi, V, Sharpe, CC & Jackson, TL 2023, 'Effect of intravitreal anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration on renal function', Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, vol. 38, no. 7, pp. 1770-1772. https://doi.org/10.1093/ndt/gfad035

Effect of intravitreal anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration on renal function. / Neffendorf, James E; Mare, Tracey; Simpson, Andrew R H et al.

In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, No. 7, 30.06.2023, p. 1770-1772.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Effect of intravitreal anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration on renal function

AU - Neffendorf, James E

AU - Mare, Tracey

AU - Simpson, Andrew R H

AU - Soare, Cristina

AU - Kirthi, Varo

AU - Sharpe, Claire C

AU - Jackson, Timothy L

PY - 2023/6/30

Y1 - 2023/6/30

N2 - This study did not find any clinically significant change in serum markers of renal function in the one month after intravitreal ranibizumab or aflibercept. It did, however, find a non-significant rise in creatinine with aflibercept, that was not seen with ranibizumab.

AB - This study did not find any clinically significant change in serum markers of renal function in the one month after intravitreal ranibizumab or aflibercept. It did, however, find a non-significant rise in creatinine with aflibercept, that was not seen with ranibizumab.

UR - http://www.scopus.com/inward/record.url?scp=85164233457&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfad035

DO - 10.1093/ndt/gfad035

M3 - Article

C2 - 36764668

SN - 0931-0509

VL - 38

SP - 1770

EP - 1772

JO - Nephrology, Dialysis, Transplantation

JF - Nephrology, Dialysis, Transplantation

IS - 7

ER -

Neffendorf JE, Mare T, Simpson ARH, Soare C, Kirthi V, Sharpe CC et al. Effect of intravitreal anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration on renal function. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2023 Jun 30;38(7):1770-1772. Epub 2023 Feb 10. doi: 10.1093/ndt/gfad035

Effect of intravitreal anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration on renal function

Abstract

Access to Document

Other files and links

Embargoed Document

Fingerprint

Cite this